Congestive Heart Failure: Worldwide Drug and Medical Device Markets
Special Offer. Now 25% off the original price of $3500.
Approximately 23 million people worldwide are afflicted with congestive heart failure (CHF), and 2 million new cases of CHF are diagnosed each year worldwide. In contrast to other cardiovascular disorders that have actually declined during the past few decades, the incidence of heart failure is on the rise. It is, in fact, the most rapidly growing cardiovascular disorder in the United States.
There is no cure for CHF short of a heart transplant. Although advances in pharmacology have led to better treatment, 50% of the patients with the most advanced stage of heart failure die within a year. Typically, heart failure patients receive several chronic oral therapies, including diuretics, ACE inhibitors, beta-blockers and inotropic agents. However, a new class of CHF drugs created by biotechnology companies will soon be on the market. These new drugs will lead the way to a revolution in the treatment of CHF and could spark a biotechnology boom similar to the AIDS breakthroughs of 1996 and 1997.
A majority of patients are treated with drug therapy, but for patients with advanced CHF, device-based therapy or transplantation are their only alternatives. A large number of patients with advanced CHF have received left ventricular assist devices, and a number of promising technologies, including biventricular pacing and defibrillators, ventricular remodeling, and ventricular assist devices represent exciting, growing markets.
Kalorama’s Congestive Heart Failure: Worldwide Drug and Medical Device Markets thoroughly reviews the current state of the markets in this expanding field, including developments in drug therapy and technological advances in the device markets.
Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).
Please note that your term must be at least three characters long and numbers will be blocked by the # sign.